
TG-89
CAS No. 936091-56-4
TG-89( —— )
Catalog No. M33687 CAS No. 936091-56-4
TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 85 | Get Quote |
![]() ![]() |
5MG | 149 | Get Quote |
![]() ![]() |
10MG | 237 | Get Quote |
![]() ![]() |
25MG | 382 | Get Quote |
![]() ![]() |
50MG | 544 | Get Quote |
![]() ![]() |
100MG | 718 | Get Quote |
![]() ![]() |
500MG | 1431 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTG-89
-
NoteResearch use only, not for human use.
-
Brief DescriptionTG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer.
-
DescriptionJAK-IN-32 (XC) is a bi-aryl meta-pyrimidine inhibitor of JAK kinase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFLT
-
RecptorFLT | JAK | c-RET
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number936091-56-4
-
Formula Weight510.65
-
Molecular FormulaC26H34N6O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cnc(Nc2cccc(CN3CCOCC3)c2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Glenn Noronha, et al. Bi-aryl meta-pyrimidine inhibitors of kinases. Patent. US20110212077A1.
molnova catalog



related products
-
FLT3-IN-2
FLT3-IN-2 is a FLT3 inhibitor with IC50 of < 1 μM.
-
MRX-2843
MRX-2843 is a potent and orally active inhibitor of MERTK and FLT3(IC50s of 1.3 nM and 0.64 nM, respectively).
-
Emavusertib
Emavusertib is a potent IRAK4/FLT3 inhibtor. CA-4948 with anti-tumor activity.